Bioanalytical Method Development and Validation
Prolytix offers a wide assortment of assays for phase-appropriate bioanalytical development. We maintain these assays throughout the life cycle of your product. We also develop de novo assays for specific biomarkers. Contact us to discuss your clinical sample development needs.
Select Areas of Expertise:
- Thrombin Generation Assay (TGA)
- Anti-Drug Antibody (ADA)
- Ligand Binding Assay (LBA)
- Neutralizing Antibodies (Nab)
- Immunogenicity
- Pharmacokinetics (PK)
Bioanalysis
You can trust Prolytix to deliver the highest quality data for your bioanalytical samples, whether you’re moving into preclincal studies, first in human, or advanced clinical trials, Prolytix can support the development of your large molecule therapeutic.
We work with all types of novel biologics, biosimilars, vaccines, and in vitro diagnostics. We navigate a variety of matrices and models to help you answer tough questions and move your product forward. And rest assured: we test all samples in our FDA-inspected facility.